This portion of our website contains archival information. Archived information should be considered accurate only as of the date listed next to the event. Archived information may be superseded by more recent information we have disclosed in later presentations, press releases, filings with the Securities and Exchange Commission or otherwise. Archived information may contain forward-looking statements. Actual results may materially differ based on several factors, including those described in the archived information, press releases and our filings with the SEC.
2010 | 2009 | 2008 | 2007 | 2006 |
- December 05, 2002
Targacept Raises $46 Million in Second Round Financing - December 05, 2002
Targacept Identifies Key Pathway Regulating Neuroprotection - October 01, 2002
Targacept and Dr. Falk Pharma Successfully Complete Phase I Studies of First in Class Drug for Ulcerative Colitis - August 27, 2002
Targacept, Inc. Acquires Marketed Drug to Expand its CNS Portfolio - August 27, 2002
Targacept Announces New Product-Focused Organizational Structure - June 21, 2002
Targacept CEO is Carolinas' Entrepreneur of the Year - June 19, 2002
Targacept Featured in June 2002 issue of Harvard Business Review - June 06, 2002
Targacept to Present at BIO 2002 International Investor Forum - April 08, 2002
Agreement Between Targacept Inc. and Aventis Pharma for Development of Drugs to Treat Diseases of the Central Nervous System - March 04, 2002
Targacept Moves to Piedmont Triad Research Park - February 25, 2002
Targacept Appoints Alan Musso as Vice President and Chief Financial Officer